WESTON, Fla., Dec. 21, 2011 (GLOBE NEWSWIRE) -- Stemlogix, LLC announced today that it has expanded the cellular products and services it offers to veterinarians and their patients. In addition to the company's current premier "in-clinic" adipose derived stem cell kits and system, the company will now provide disposable kits that will allow veterinarians to produce stem cell therapy from bone marrow aspirate using the same system. The Stemlogix system provides veterinarians the ability to produce stem cell therapy "in-house" or "stall-side" in a convenient, affordable, same-day procedure. Stemlogix will also offer culture expanded bone marrow and adipose stem cells. Veterinary patients will now have the option to bank their stem cells for future use as well.
